Task: Answer the multiple-choice question.
Question: Which drug exhibits a -21.377% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) O=C(NCCC1=CCCCC1)c1ccc2c(=O)n3c(nc2c1)CCCCC3
(b) Cc1ccc(NC2=C(N3CCOCC3)C(=O)c3ccccc3C2=O)cc1
Answer: b. Cc1ccc(NC2=C(N3CCOCC3)C(=O)c3ccccc3C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC2=C(N3CCOCC3)C(=O)c3ccccc3C2=O)cc1
Cc1ccc(NC2=C(N3CCOCC3)C(=O)c3ccccc3C2=O)cc1
2-(4-methylanilino)-3-morpholin-4-ylnaphthalene-1,4-dione